Wegovy Sees Uptick, But Novo Faces Investor Skepticism
The U.S. ban on copycat versions of Novo Nordisk's weight-loss drug Wegovy has resulted in early increased demand but investors want more evidence of growth before the...
Read moreDetailsThe U.S. ban on copycat versions of Novo Nordisk's weight-loss drug Wegovy has resulted in early increased demand but investors want more evidence of growth before the...
Read moreDetailsOppenheimer Asset Management increased its S&P 500 year-end prediction to 7,100 which represents the highest Wall Street estimate because of improving trade relations and strong corporate earnings...
Read moreDetailsBrazilian coffee producers face a significant U.S. tariff hike starting August 1 which threatens to damage their export business while lowering domestic coffee prices. The U.S. will...
Read moreDetailsThe Phillips 66 company achieved better-than-forecasted second-quarter earnings results because of increased refining profit margins and decreased maintenance expenses which allowed the American fuel manufacturer to...
Read moreDetailsDuring his Thursday address President Donald Trump declared a major victory for U.S. beef exporters because Australia decided to lift its previous import restrictions. Canberra announced the change...
Read moreDetails